For research use only. Not for therapeutic Use.
Moexipril-d4 Hydrochloride is a deuterated form of moexipril, an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure and heart failure. In this version, four hydrogen atoms are replaced with deuterium, enhancing its utility in pharmacokinetic and metabolic studies. The deuterium labeling allows for precise tracking and analysis using mass spectrometry and NMR spectroscopy. The hydrochloride salt form improves solubility and stability. Despite the isotopic modification, Moexipril-d4 retains the same therapeutic properties as the non-deuterated form, making it valuable for research purposes.
| Catalog Number | R044134 |
| CAS Number | NA |
| Synonyms | (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid-d4 Hydrochloride; CI-925-d4; RS-10085-197-d4; SPM-925-d4; Fempress-d4; Perdix-d4; Univasc-d4; |
| Molecular Formula | C₂₇H₃₁D₄ClN₂O₇ |
| Purity | ≥95% |
| Storage | -20°C |
